Prednisolone Dosing for Bell's Palsy
For adults and adolescents ≥16 years presenting within 72 hours of Bell's palsy onset, prescribe a 10-day course of oral prednisolone: either 50 mg daily for 10 days OR 60 mg daily for 5 days followed by a 5-day taper. 1
Recommended Dosing Regimens
The American Academy of Otolaryngology-Head and Neck Surgery guidelines provide two evidence-based options 1:
- Option 1: Prednisolone 25 mg twice daily (50 mg total) for 10 days
- Option 2: Prednisolone 60 mg daily for 5 days, then taper over 5 days
Both regimens are supported by high-quality randomized controlled trials (Sullivan et al. and Engstrom et al.) that demonstrated significant improvement in facial nerve recovery 1.
Critical Timing Considerations
Treatment must be initiated within 72 hours of symptom onset for maximum benefit 1. The evidence shows:
- Treatment within 72 hours: 83% complete recovery at 3 months versus 63.6% with placebo (p<0.001) 1
- At 9 months: 94.4% recovery with prednisolone versus 81.6% with placebo 1
- Treatment after 72 hours has unclear benefit 1
Research suggests even earlier treatment (within 3 days) may yield superior outcomes, with some studies showing 100% recovery when combined therapy is started within this window 2, 3.
Evidence for Higher Doses
While the guidelines recommend 50-60 mg daily, emerging research suggests potential benefit from higher doses in severe cases:
- High-dose regimens (≥120 mg prednisolone equivalent daily) showed reduced non-recovery rates compared to standard doses (60 mg) 4, 5, 6
- One propensity-score analysis found high-dose corticosteroids decreased non-recovery from 13.1% to 7.8% (p=0.040) 4
- The benefit was most pronounced in severe Bell's palsy (Yanagihara score 0-10) when treated within 3 days of onset 4
However, these higher doses are not yet incorporated into formal guidelines and should be considered investigational 5, 6.
Special Populations
Children (<16 years)
Evidence for steroid use in children is limited and inconclusive 1. A recent high-quality RCT in children showed no significant benefit from prednisolone, with 99% recovery in the treatment group versus 93% in placebo at 6 months 7. If treating pediatric patients, involve caregivers in shared decision-making given the uncertain benefit-harm ratio 1.
Important Clinical Caveats
- Do NOT use antiviral monotherapy - it is no better than placebo 1
- Combination therapy (prednisolone + antivirals) may be offered as an option, though evidence is mixed 1
- Severe facial paralysis, delayed treatment >7 days, hearing defects, and recurrence history are poor prognostic factors even with treatment 8
- No tapering is necessary after the 10-day course for standard regimens 1
Route of Administration
While oral prednisolone is standard, one meta-analysis suggested IV methylprednisolone may provide faster recovery to grade 1 at 1 month (particularly for grade 4 palsy), though no difference exists at 3 months 9. Oral administration remains the guideline-recommended approach given equivalent long-term outcomes and practical advantages 1.